HH
GPCR icon

HSG Holding’s Structure Therapeutics GPCR Stock Holding History

HSG Holding’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.3M Hold
266,062
– – 1.19% 10
2026
Q1 		$6.2M Hold
266,062
– – 0.38% 13
2025
Q4 		$24.4M Hold
266,062
– – 1.29% 9
2025
Q3 		$4.61M Hold
266,062
– – 0.24% 13
2025
Q2 		$5.52M Hold
266,062
– – 0.28% 13
2025
Q1 		$6.2M Hold
266,062
– – 0.36% 11
2024
Q4 		$7.54M Hold
266,062
– – 0.31% 12
2024
Q3 		$10.3M Hold
266,062
– – 0.4% 10
2024
Q2 		$10.3M Sell
266,062
-798,920
-75% -$32.8M 0.38% 10
2024
Q1 		$38.4M Sell
1,064,982
-244
-0% -$10.3K 3.56% 7
2023
Q4 		$44.1M Hold
1,065,226
– – 5.07% 6
2023
Q3 		$53.7M Buy
+1,065,226
New +$34.3M 5.76% 6

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

HSG Holding's GPCR Position: Q2 2026 in Review

HSG Holding held its Structure Therapeutics (GPCR) position steady in Q2 2026 at 266,062 shares worth $14.3M. The position accounts for 1.19% of the portfolio, ranked #10.

HSG Holding first reported a position in GPCR in Q3 2023 and has held it in 12 quarters since. The position peaked at $53.7M in Q3 2023. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • HSG Holding held 266,062 shares of Structure Therapeutics worth $14.3M as of Q2 2026.
  • HSG Holding left its Structure Therapeutics share count unchanged in Q2 2026.
  • Structure Therapeutics made up 1.19% of HSG Holding's portfolio in Q2 2026, its #10 holding.
  • HSG Holding first reported a position in Structure Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • HSG Holding's Structure Therapeutics position peaked at $53.7M in Q3 2023.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on HSG Holding's 13F filing for Q2 2026, filed 13 Aug 2026.